Treatment-related severe and fatal adverse events with molecular targeted agents in the treatment of advanced gastric cancer: a meta-analysis

AIM: To perform a systematic review and meta-analysis of Phase III randomized controlled trials (RCTs) to determine the incidence and risk of severe adverse events (AEs) with molecular targeted agents (MTAs) in advanced/metastatic gastric cancer (GC) patients. METHODS: A comprehensive literature sea...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Liang, Liu, Yagang, Zhou, Wenyong, Li, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414625/
https://www.ncbi.nlm.nih.gov/pubmed/28490885
http://dx.doi.org/10.2147/OTT.S110431

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414625/
https://www.ncbi.nlm.nih.gov/pubmed/28490885
http://dx.doi.org/10.2147/OTT.S110431

Ejemplares similares